on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Announces Reverse Stock Split
Jaguar Health, Inc. plans a reverse stock split, effective March 24, 2025, with a 1-for-25 ratio. This measure aims to comply with Nasdaq's listing standards. Post-split, shares will trade under the symbol "JAGX" on the Nasdaq Capital Market. The new CUSIP is 47010C888.
The decision, ratified at a Special Meeting of Stockholders, seeks to attract institutional investors by enhancing share price and count. Fractional shares will not be issued; cash payments will be given instead. Equiniti Trust Company, LLC oversees the process for stockholders to exchange certificates.
Jaguar Health, a pharmaceutical company, focuses on developing medications derived from plants for gastrointestinal issues. The reverse split aligns with their strategic goals.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news